Detalhe da pesquisa
1.
Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAFV600-mutated melanoma.
ESMO Open
; 8(6): 102038, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37922690